Related Experiment Video
Updated: Aug 12, 2026
11:08
The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
Published on: March 13, 2014
Intrahepatic cholestasis of pregnancy
1Departments of Medicine and Pediatrics, Sections of Hepatology and Pediatric Gastroenterology and Nutrition, Rush Presbyterian-St. Luke's Medical Center, Chicago, Illinois, USA. efagan@rush.edu
Clinics in Liver Disease
|April 9, 2001
Summary
Intrahepatic cholestasis of pregnancy (ICP) affects maternal and fetal health due to elevated bile acids. Early detection and ursodeoxycholic acid treatment improve outcomes, but careful monitoring and timely delivery remain crucial.
Area of Science:
- Hepatology
- Maternal-Fetal Medicine
- Biochemistry
Background:
- Intrahepatic cholestasis of pregnancy (ICP) is a serious liver disorder impacting maternal and fetal health.
- It is characterized by elevated maternal bile acids, potentially toxic to the fetus.
- The exact cause is unknown but involves genetic predisposition and hormonal influences.
Purpose of the Study:
- To summarize the understanding of ICP's pathophysiology and clinical implications.
- To outline current management strategies focusing on maternal and fetal well-being.
- To review the efficacy and safety of ursodeoxycholic acid in ICP management.
Main Methods:
- Literature review of ICP pathophysiology, diagnosis, and management.
- Analysis of clinical outcomes related to maternal bile acid levels and fetal monitoring.
- Evaluation of therapeutic interventions, particularly ursodeoxycholic acid.
Main Results:
- ICP increases risks of fetal distress, preterm delivery, and fetal death.
- Maternal bile acid levels and ALT do not reliably predict fetal complications.
- Ursodeoxycholic acid shows efficacy in reducing pruritus and normalizing biochemical markers, with limited data on fetal safety.
Conclusions:
- ICP requires early identification, close monitoring, and prompt delivery upon fetal maturity.
- Management aims to mitigate fetal risks and maternal symptoms.
- Ursodeoxycholic acid is a promising treatment, but further research is needed on its long-term fetal effects.
Related Concept Videos
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:24Chronic Pancreatitis I: Introduction
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:22Portal Hypertension
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
01:20Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...